YOLT-102

N/A

Report date: 2025/09/05 14:00:04

Base Information

Drug NameYOLT-102
Drug Alias NameYOLT-102
ClassificationCell and gene therapy > Gene therapy > Gene editing
Mechanisms of ActionGene expression modulators
TargetsUpdating
Therapy Area/IndicationsMetabolic DiseasesAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Yaotang Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Yaotang Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsMetabolic DiseasesAtherosclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A